These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 5987135)
1. [A new aspect of the pathomechanism of glaucoma attack]. Orbán T; Hanisch J; Vereb K Klin Monbl Augenheilkd; 1966; 149(6):847-58. PubMed ID: 5987135 [No Abstract] [Full Text] [Related]
2. [The effect of Atromid in glaucoma]. Orbán T; Hanisch J; Katalin V Orv Hetil; 1967 May; 108(19):873-6. PubMed ID: 6077204 [No Abstract] [Full Text] [Related]
3. [Clinical-experimental studies on lipid metabolism using Regelan]. Hammerl H Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575 [No Abstract] [Full Text] [Related]
4. Clofibrate in glaucoma. Orbán T Lancet; 1968 Jan; 1(7532):47. PubMed ID: 4169091 [No Abstract] [Full Text] [Related]
5. The effect of clofibrate on open-angle glaucoma. Marrs JM; Rowe KW Arch Ophthalmol; 1969 Jul; 82(1):19-20. PubMed ID: 5791497 [No Abstract] [Full Text] [Related]
6. Communications. Action of Atromid-S (clofibrate) on intra-ocular pressure. Gloster J; Hartley RE; Perkins ES Br J Ophthalmol; 1968 Nov; 52(11):793-800. PubMed ID: 4972749 [No Abstract] [Full Text] [Related]
7. Divergent effects in the treatment of hyperlipemia. Slowe IA; Carter AC; Feldman EB Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355 [No Abstract] [Full Text] [Related]
8. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone. Schatz IJ Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188 [No Abstract] [Full Text] [Related]
9. Laboratory indices in clofibrate therapy of juvenile-onset diabetes. Narduzzi JV; Danowski TS; Weir TF; Alley RA; Vester JW; Moses C Clin Pharmacol Ther; 1967; 8(6):817-23. PubMed ID: 4862480 [No Abstract] [Full Text] [Related]
10. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia]. De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027 [No Abstract] [Full Text] [Related]
11. [CPIB: a hypolipidemic agent. Study of 20 patients]. Verdy M Union Med Can; 1966 Sep; 95(9):1049-52. PubMed ID: 5913817 [No Abstract] [Full Text] [Related]
12. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases]. Warembourg H; Jaillard J Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637 [No Abstract] [Full Text] [Related]
13. [Action of a 2.2 percent solution of androsterone, in chlorphenisate, on the serum lipoproteins of low density (LDL) in patients resistant to diet therapy]. Bertolami V; Schneiderman B; Finatti AA; Netto RF Arq Bras Cardiol; 1966 Apr; 19(2):111-26. PubMed ID: 5943772 [No Abstract] [Full Text] [Related]
14. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons]. Rilliet B; Monnier J Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485 [No Abstract] [Full Text] [Related]
15. A controlled trial of Atromid therapy in exudative diabetic retinopathy. Cullen JF; Ireland JT; Oliver MF Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423 [No Abstract] [Full Text] [Related]
16. [Contributions on the eye pressure decreasing effect mechanism of glycerin]. Hanisch J; Orbán T; Vereb K; Hegedüs A Klin Monbl Augenheilkd; 1967; 151(1):87-91. PubMed ID: 5595984 [No Abstract] [Full Text] [Related]
17. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis]. Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081 [No Abstract] [Full Text] [Related]
18. [Recent aspects in the pathomechanism of glaucoma (author's transl)]. Weinstein P Klin Monbl Augenheilkd; 1977 Jan; 170(1):49-50. PubMed ID: 850356 [TBL] [Abstract][Full Text] [Related]